These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37026581)

  • 1. Rethinking human cytomegalovirus latency reservoir.
    Schwartz M; Stern-Ginossar N
    Ann N Y Acad Sci; 2023 Jun; 1524(1):30-36. PubMed ID: 37026581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing.
    Shnayder M; Nachshon A; Krishna B; Poole E; Boshkov A; Binyamin A; Maza I; Sinclair J; Schwartz M; Stern-Ginossar N
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of human cytomegalovirus persistence and latency.
    Jarvis MA; Nelson JA
    Front Biosci; 2002 Jun; 7():d1575-82. PubMed ID: 12045013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.
    Krishna BA; Poole EL; Jackson SE; Smit MJ; Wills MR; Sinclair JH
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34
    Crawford LB; Hancock MH; Struthers HM; Streblow DN; Yurochko AD; Caposio P; Goodrum FD; Nelson JA
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCMV Antivirals and Strategies to Target the Latent Reservoir.
    Perera MR; Wills MR; Sinclair JH
    Viruses; 2021 May; 13(5):. PubMed ID: 34062863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus manipulation of latently infected cells.
    Sinclair JH; Reeves MB
    Viruses; 2013 Nov; 5(11):2803-24. PubMed ID: 24284875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients.
    Van Damme E; Sauviller S; Lau B; Kesteleyn B; Griffiths P; Burroughs A; Emery V; Sinclair J; Van Loock M
    J Gen Virol; 2015 Jan; 96(Pt 1):131-143. PubMed ID: 25312585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latency and reactivation of human cytomegalovirus.
    Sinclair J; Sissons P
    J Gen Virol; 2006 Jul; 87(Pt 7):1763-1779. PubMed ID: 16760381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iTRAQ-Based Proteomics Analysis of Human Cytomegalovirus Latency and Reactivation in T98G Cells.
    Cheng S; Zhao F; Wen L; Yang B; Wang XZ; Huang SN; Jiang X; Zeng WB; Sun JY; Zhang FK; Shen HJ; Fortunato E; Luo MH; Cheng H
    J Virol; 2022 Jan; 96(2):e0147621. PubMed ID: 34730396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency.
    Elder EG; Krishna BA; Williamson J; Lim EY; Poole E; Sedikides GX; Wills M; O'Connor CM; Lehner PJ; Sinclair J
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Model Systems for Human Cytomegalovirus Latency and Reactivation.
    Crawford LB; Diggins NL; Caposio P; Hancock MH
    mBio; 2022 Feb; 13(1):e0172421. PubMed ID: 35012351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation.
    Collins-McMillen D; Buehler J; Peppenelli M; Goodrum F
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30127257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latency and reactivation of human cytomegalovirus.
    Sissons JG; Bain M; Wills MR
    J Infect; 2002 Feb; 44(2):73-7. PubMed ID: 12076064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Human Cytomegalovirus
    Mlera L; Moy M; Maness K; Tran LN; Goodrum FD
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32630219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus: Latency and reactivation in the myeloid lineage.
    Sinclair J
    J Clin Virol; 2008 Mar; 41(3):180-5. PubMed ID: 18164651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of human cytomegalovirus latency: an update.
    Kumar A; Herbein G
    Epigenomics; 2014; 6(5):533-46. PubMed ID: 25431945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel murine model of differentiation-mediated cytomegalovirus reactivation from latently infected bone marrow haematopoietic cells.
    Liu XF; Swaminathan S; Yan S; Engelmann F; Abbott DA; VanOsdol LA; Heald-Sargent T; Qiu L; Chen Q; Iovane A; Zhang Z; Abecassis MM
    J Gen Virol; 2019 Dec; 100(12):1680-1694. PubMed ID: 31647403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of human cytomegalovirus latency and reactivation.
    Reeves M; Sinclair J
    Curr Top Microbiol Immunol; 2008; 325():297-313. PubMed ID: 18637513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X Receptor-Inducible Host E3 Ligase IDOL Targets a Human Cytomegalovirus Reactivation Determinant.
    Mlera L; Collins-McMillen D; Zeltzer S; Buehler JC; Moy M; Zarrella K; Caviness K; Cicchini L; Tafoya DJ; Goodrum F
    J Virol; 2023 Jul; 97(7):e0075823. PubMed ID: 37338407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.